1Suppliers
0Customers
1Debt Items
0Related Chains

Cardiol Therapeutics Inc. Suppliers

TickerNameConfidenceEvidence
DALTON DALTON 92% Dalton has the manufacturing capability for Cardiol’s clinical trial materials, scalable to support all stages of the drug development process (Phase I, II, III, and commercial).

Cardiol Therapeutics Inc. Customers

No clients on recordNo downstream customers found in our database for Cardiol Therapeutics Inc..

Cardiol Therapeutics Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CRDL-DEBT Debt stack $84,678 90% Market cache reports total debt of $84,678.

Cardiol Therapeutics Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cardiol Therapeutics Inc..

Cardiol Therapeutics Inc. Ownership

HolderNameConfidenceEvidence
CRDL-OWNER-MMCAP-INTERNATIONAL-INC-SPC MMCAP International Inc. SPC 90% 13F overlay lists MMCAP International Inc. SPC as top holder; 46 tracked holders.

Cardiol Therapeutics Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.